TABLE 4.
Risk factors for 30-day mortality in patients with COVID-19.
Univariate model | Multivariate model | |||
HR (95% CI) | P-value | Adjusted HR (95% CI) | P-value | |
Severity of hyponatremia | ||||
Mild | 1.56 (1.44–1.70) | <0.001 | ||
Moderate | 2.76 (2.47–3.09) | <0.001 | 1.24 (1.04–1.48) | 0.02 |
Severe | 3.02 (2.65–3.44) | <0.001 | 1.71 (1.40–2.09) | <0.001 |
Demographics | ||||
Age | 1.06 (1.06–1.06) | <0.001 | 1.03 (1.03–1.04) | <0.001 |
Male sex | 1.35 (1.27–1.43) | <0.001 | ||
Comorbidities | ||||
Diabetes mellitus | 1.71 (1.61–1.83) | <0.001 | ||
Hypertension | 2.37 (2.22–2.52) | <0.001 | ||
Ischemic heart disease | 1.97 (1.83–2.12) | <0.001 | ||
Cerebrovascular accident | 2.31 (2.15–2.50) | <0.001 | 1.19 (1.04–1.36) | 0.01 |
COAD | 2.07 (1.87–2.29) | <0.001 | 1.51 (1.27–1.81) | <0.001 |
Active malignancy | 1.56 (1.45–1.68) | <0.001 | ||
Dementia | 2.62 (2.45–2.81) | <0.001 | ||
Congestive heart failure | 2.48 (2.29–2.68) | <0.001 | ||
Arrhythmia | 2.28 (2.13–2.45) | <0.001 | 1.23 (1.08–1.41) | 0.002 |
Chronic liver disease | 1.50 (1.35–1.67) | <0.001 | ||
Laboratory parameters | ||||
SARS-CoV-2 PCR Ct value | 0.97 (0.96–0.97) | <0.001 | 0.98 (0.97–0.99) | <0.001 |
Hemoglobin | 0.79 (0.78–0.80) | <0.001 | 0.97 (0.94–0.99) | 0.01 |
White cell count | 1.02 (1.02–1.02) | <0.001 | 1.02 (1.01–1.03) | <0.001 |
eGFR (by CKD-EPI equation) | 0.97 (0.97–0.97) | <0.001 | 0.99 (0.99–0.99) | <0.001 |
Albumin | 0.88 (0.87–0.88) | <0.001 | 0.95 (0.94–0.96) | <0.001 |
C-reactive protein | 1.10 (1.10–1.11) | <0.001 | 1.07 (1.06–1.08) | <0.001 |
D-dimer (for every 1,000 ng/ml rise) | 1.22 (1.20–1.23) | <0.001 | 1.03 (1.01–1.06) | 0.008 |
COVID-19, coronavirus disease-2019; CI, confidence interval; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; RT-PCR, reverse transcription polymerase chain reaction; Ct value, cycle threshold value; COAD, chronic obstructive airway disease; eGFR, estimated glomerular filtration rate; CKD-EPI, chronic kidney disease epidemiology collaboration.